APP and Alzheimer disease: Moreover, no significant Aβ accumulation was observed in preclinical AD mice (4‐month‐old APP/PS1), but they had significant bone vessel injury and bone loss, indicating there may be other mechanisms regulating bone loss of preclinical AD mice.